Comparison of select cancer biomarkers in human circulating and bulk tumor cells using magnetic nanoparticles and a miniaturized micro-NMR system

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 9, Issue 7, 2013, Pages 1009-1017

  Ghazani, Arezou A ^a,b   McDermott, Shaunagh ^a,b   Pectasides, Melina ^a,b   Sebas, Matt ^a   Mino Kenudson, Mari ^a   Lee, Hakho ^a,b   Weissleder, Ralph ^a,b,c   Castro, Cesar M ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

Circulating tumor cells; Magnetic nanoparticles; Micro NMR ( NMR); Point of care diagnostics

Indexed keywords

CANCER BIOMARKERS; CIRCULATING TUMOR CELLS; FINE NEEDLE BIOPSY; MAGNETIC NANO-PARTICLES; MICROFLUIDIC-BASED; PERIPHERAL BLOOD; POINT-OF-CARE DIAGNOSTICS; WEAK CORRELATION;

BLOOD; CELLS; DISEASES; ENZYME INHIBITION; NANOPARTICLES; TUMORS;

BIOPSY;

EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITHELIAL CELL ADHESION MOLECULE; MAGNETIC NANOPARTICLE; VIMENTIN;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; CANCER PATIENT; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; EPITHELIUM TUMOR; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; HUMAN CELL; IMAGE GUIDED BIOPSY; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; SOLID EPITHELIAL CANCER; SOLID TUMOR; TUMOR BIOPSY;

CIRCULATING TUMOR CELLS; MAGNETIC NANOPARTICLES; MICRO-NMR (ΜNMR); POINT-OF-CARE DIAGNOSTICS;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MAGNETITE NANOPARTICLES; MALE; MIDDLE AGED; MINIATURIZATION; NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; TUMOR MARKERS, BIOLOGICAL;

EID: 84884280606     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2013.03.011     Document Type: Article

References (45)

1. Cristofanilli M., Budd G.T., Ellis M.J., Stopeck A., Matera J., Miller M.C., et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004, 351(8):781-791.
2. Botteri E., Sandri M.T., Bagnardi V., Munzone E., Zorzino L., Rotmensz N., et al. Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer. Breast Cancer Res Treat 2010, 122(1):211-217.
3. Yu M., Stott S., Toner M., Maheswaran S., Haber D.A. Circulating tumor cells: approaches to isolation and characterization. J Cell Biol 2011, 192(3):373-382.
4. Danila D.C., Heller G., Gignac G.A., Gonzalez-Espinoza R., Anand A., Tanaka E., et al. Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clin Cancer Res 2007, 13(23):7053-7058.
5. de Bono J.S., Scher H.I., Montgomery R.B., Parker C., Miller M.C., Tissing H., et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 2008, 14(19):6302-6309.
6. Okegawa T., Nutahara K., Higashihara E. Prognostic significance of circulating tumor cells in patients with hormone refractory prostate cancer. J Urol 2009, 181(3):1091-1097.
7. Lang J.M., Casavant B.P. Circulating Tumor Cells: Getting More from Less. Transl Med 2012, 4(141):141.
8. Mirnezami R., Nicholson J., Darzi A. Preparing for precision medicine. N Engl J Med 2012, 366(6):489-491.
9. Coumans F.A.W., Doggen C.J.M., Attard G., De Bono J.S., Terstappen L.W.M.M. All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer. Ann Oncol 2010, 21(9):1851-1857.
10. Haun J.B., Castro C.M., Wang R., Peterson V.M., Marinelli B.S., Lee H., et al. Micro-NMR for rapid molecular analysis of human tumor samples. Sci Transl Med 2011, 3(71):71ra16.
11. Maheswaran S., Sequist L.V., Nagrath S., Ulkus L., Brannigan B., Collura C.V., et al. Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 2008, 359(4):366-377.
12. Connelly M., Wang Y., Doyle G.V., Terstappen L., McCormack R. Re: Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J Natl Cancer Inst 2009, 101(12):895. [author reply 896-895; author reply 897].
13. Ghazani A.A., Castro C.M., Gorbatov R., Lee H., Weissleder R. Sensitive and direct detection of circulating tumor cells by multimarker micro-nuclear magnetic resonance. Neoplasia 2012, 14(5):388-395.
14. Bendall S.C., Simonds E.F., Qiu P., Amir E.-D., Krutzik P.O., Finck R., et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Sci Signal 2011, 332(6030):687.
15. Brennan D.J., O'Connor D.P., Rexhepaj E., Ponten F., Gallagher W.M. Antibody-based proteomics: fast-tracking molecular diagnostics in oncology. Nat Rev Cancer 2010, 10(9):605-617.
16. Nagrath S., Sequist L.V., Maheswaran S., Bell D.W., Irimia D., Ulkus L., et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007, 450(7173):1235-1239.
17. Homola J. Surface plasmon resonance sensors for detection of chemical and biological species. Chem Rev 2008, 108(2):462.
18. Sun T., Holmes D., Gawad S., Green N.G., Morgan H. High speed multi-frequency impedance analysis of single particles in a microfluidic cytometer using maximum length sequences. Lab Chip 2007, 7(8):1034-1040.
19. Gu B., Park T.J., Ahn J., Huang X., Lee S.Y., Choi Y. Nanogap field-effect transistor biosensors for electrical detection of avian influenza. small 2009, 5(21):2407-2412.
20. Sorger P.K. Microfluidics closes in on point-of-care assays. Nat Biotechnol 2008, 26(12):1345-1346.
21. Haun J.B., Yoon T.J., Lee H., Weissleder R. Molecular detection of biomarkers and cells using magnetic nanoparticles and diagnostic magnetic resonance. Methods Mol Biol 2011, 72633-72649.
22. Lee H., Sun E., Ham D., Weissleder R. Chip-NMR biosensor for detection and molecular analysis of cells. Nat Med 2008, 14(8):869-874.
23. Lee H., Yoon T.J., Figueiredo J.L., Swirski F.K., Weissleder R. Rapid detection and profiling of cancer cells in fine-needle aspirates. Proc Natl Acad Sci U S A 2009, 106(30):12459-12464.
24. Shao H., Min C., Issadore D., Liong M., Yoon T.-J., Weissleder R., et al. Magnetic nanoparticles and microNMR for diagnostic applications. Theranostics 2012, 2(1):55.
25. McInroy L., Maatta A. Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion. Biochem Biophys Res Commun 2007, 360(1):109-114.
26. Barriere G., Riouallon A., Renaudie J., Tartary M., Rigaud M. Mesenchymal characterization: alternative to simple CTC detection in two clinical trials. Anticancer Res 2012, 32(8):3363-3369.
27. Connelly L., Barham W., Onishko H.M., Chen L., Sherrill T.P., Zabuawala T., et al. NF-kappaB activation within macrophages leads to an anti-tumor phenotype in a mammary tumor lung metastasis model. Breast Cancer Res 2011, 13(4):R83.
28. Haun J.B., Devaraj N.K., Hilderbrand S.A., Lee H., Weissleder R. Bioorthogonal chemistry amplifies nanoparticle binding and enhances the sensitivity of cell detection. Nat Nanotechnol 2010, 5(9):660-665.
29. Tsuji T., Ibaragi S., Shima K., Hu M.G., Katsurano M., Sasaki A., et al. Epithelial-mesenchymal transition induced by growth suppressor p12CDK2-AP1 promotes tumor cell local invasion but suppresses distant colony growth. Cancer Res 2008, 68(24):10377-10386.
30. Tsuji T., Ibaragi S., Hu G.F. Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res 2009, 69(18):7135-7139.
31. Issadore D., Min C., Liong M., Chung J., Weissleder R., Lee H. Miniature magnetic resonance system for point-of-care diagnostics. Lab Chip 2011, 11(13):2282-2287.
32. Bolke E., Orth K., Gerber P.A., Lammering G., Mota R., Peiper M., et al. Gene expression of circulating tumour cells and its correlation with tumour stage in breast cancer patients. Eur J Med Res 2009, 14(8):359-363.
33. Strati A., Markou A., Parisi C., Politaki E., Mavroudis D., Georgoulias V., et al. Gene expression profile of circulating tumor cells in breast cancer by RT-qPCR. BMC Cancer 2011, 11422.
34. Smirnov D.A., Zweitzig D.R., Foulk B.W., Miller M.C., Doyle G.V., Pienta K.J., et al. Global gene expression profiling of circulating tumor cells. Cancer Res 2005, 65(12):4993-4997.
35. Lee J.H., Huh Y.M., Jun Y.W., Seo J.W., Jang J.T., Song H.T., et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med 2007, 13(1):95-99.
36. Yoon T.J., Lee H., Shao H., Weissleder R. Highly magnetic core-shell nanoparticles with a unique magnetization mechanism. Angew Chem Int Ed Engl 2011, 50(20):4663-4666.
37. Yoon T.J., Lee H., Shao H., Hilderbrand S.A., Weissleder R. Multicore assemblies potentiate magnetic properties of biomagnetic nanoparticles. Adv Mater 2011, 23(41):4793-4797.
38. Agasti S.S., Liong M., Tassa C., Chung H.J., Shaw S.Y., Lee H., et al. Supramolecular host-guest interaction for labeling and detection of cellular biomarkers. Angew Chem Int Ed Engl 2012, 51(2):450-454.
39. Liong M., Tassa C., Shaw S.Y., Lee H., Weissleder R. Multiplexed magnetic labeling amplification using oligonucleotide hybridization. Adv Mater 2011, 23(36):H254-H257.
40. Steinberg I., Ben-David M., Gannot I. A new method for tumor detection using induced acoustic waves from tagged magnetic nanoparticles. Nanomedicine: Nanotechnology 2011.
41. Martinez-Boubeta C., Balcells L., Cristòfol R., Sanfeliu C., Rodríguez E., Weissleder R., et al. Self-assembled multifunctional Fe/MgO nanospheres for magnetic resonance imaging and hyperthermia. Nanomedicine: Nanotechnol Biol Med 2010, 6(2):362-370.
42. Brullot W., Valev V.K., Verbiest T. Magnetic-plasmonic nanoparticles for the life sciences: calculated optical properties of hybrid structures. Nanomedicine: Nanotechnol Biol Med 2012, 8(5):559-568.
43. Issadore D., Chung J., Shao H., Liong M., Ghazani A.A., Castro C.M., et al. Ultrasensitive clinical enumeration of rare cells ex vivo using a micro-hall detector. Sci Transl Med 2012, 4(141):141ra92.
44. Loureiro J., Andrade P.Z., Cardoso S., da Silva C.L., Cabral J.M., Freitas P.P. Magnetoresistive chip cytometer. Lab Chip 2011, 11(13):2255-2261.
45. Nam J.M., Thaxton C.S., Mirkin C.A. Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science 2003, 301(5641):1884-1886.